Susquehanna International Group, LLP Aerie Pharmaceuticals Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $66,248 - $158,392	10,400 Added 85.25%	22,600 $342,000
Q2 2022 Aug 15, 2022	BUY	$4.95 - $9.16 $8,910 - $16,488	1,800 Added 17.31%	12,200 $92,000
Q1 2022 May 16, 2022	SELL	$5.64 - $9.8 $320,352 - $556,640	-56,800 Reduced 84.52%	10,400 $95,000
Q4 2021 Feb 14, 2022	BUY	$7.02 - $13.33 $302,562 - $574,523	43,100 Added 178.84%	67,200 $472,000
Q4 2020 Feb 16, 2021	BUY	$9.12 - $14.49 $65,664 - $104,328	7,200 Added 42.6%	24,100 $326,000
Q2 2020 Aug 14, 2020	BUY	$12.0 - $16.13 $14,400 - $19,356	1,200 Added 7.64%	16,900 $249,000
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $1.45 Million - $3.13 Million	-122,600 Reduced 88.65%	15,700 $212,000
Q4 2019 Feb 14, 2020	BUY	$17.72 - $25.1 $1.16 Million - $1.65 Million	65,700 Added 90.5%	138,300 $3.34 Million
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $184,100 - $280,000	10,000 Added 15.97%	72,600 $1.4 Million
Q2 2019 Aug 14, 2019	SELL	$28.97 - $48.21 $567,812 - $944,916	-19,600 Reduced 23.84%	62,600 $1.85 Million
Q1 2019 May 15, 2019	SELL	$36.32 - $49.25 $2.22 Million - $3 Million	-61,000 Reduced 42.6%	82,200 $3.91 Million
Q4 2018 Feb 14, 2019	BUY	$33.0 - $60.04 $211,200 - $384,256	6,400 Added 4.68%	143,200 $5.17 Million
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $685,030 - $901,580	12,200 Added 9.79%	136,800 $8.42 Million
Q2 2018 Aug 14, 2018	SELL	$47.85 - $70.45 $3.74 Million - $5.5 Million	-78,100 Reduced 38.53%	124,600 $8.42 Million
Q1 2018 May 15, 2018	BUY	$51.15 - $61.0 $1.64 Million - $1.96 Million	32,100 Added 18.82%	202,700 $11 Million
Q4 2017 Feb 14, 2018	SELL	$50.85 - $65.1 $8.05 Million - $10.3 Million	-158,300 Reduced 48.13%	170,600 $10.2 Million
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $16 Million - $19.8 Million	328,900	328,900 $16 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account